ARVN
Arvinas, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.41
+1.05%0
Insider buys (3m)
2
Insider sells (3m)
-$66.0K
Net value (3m)
+26.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 26, 2026 | Bain Linda · director | A-Award | 22,714 | $8.05 |
| Jun 26, 2026 | Kennedy Edward Moore Jr. · director | A-Award | 22,714 | $8.05 |
| Jun 26, 2026 | Cunningham Everett · director | A-Award | 15,527 | $0.00 |
| Jun 26, 2026 | Norwalk Leslie V · director | A-Award | 15,527 | $0.00 |
| Jun 26, 2026 | Smaldone Alsup Laurie · director | A-Award | 15,527 | $0.00 |
| Jun 26, 2026 | Norwalk Leslie V · director | A-Award | 22,714 | $8.05 |
| Jun 26, 2026 | Smaldone Alsup Laurie · director | A-Award | 22,714 | $8.05 |
| Jun 26, 2026 | Bain Linda · director | A-Award | 15,527 | $0.00 |
| Jun 26, 2026 | Kennedy Edward Moore Jr. · director | A-Award | 15,527 | $0.00 |
| Jun 26, 2026 | Cunningham Everett · director | A-Award | 22,714 | $8.05 |
| Jun 26, 2026 | Morrison Briggs · director | A-Award | 22,714 | $8.05 |
| Jun 26, 2026 | Morrison Briggs · director | A-Award | 15,527 | $0.00 |
| Jun 24, 2026 | Saik Andrew · officer: Chief Financial Officer | Sale | 5,696 | $8.16 |
| Jun 18, 2026 | Cacace Angela M · officer: Chief Scientific Officer | Sale | 2,576 | $7.59 |
| May 22, 2026 | Teel Randy · director, officer: President and CEO | Sale | 2,209 | $9.04 |
| May 13, 2026 | Berkowitz Noah · officer: Chief Medical Officer | Sale | 11,108 | $9.94 |
| May 13, 2026 | Teel Randy · director, officer: President and CEO | Sale | 9,657 | $9.94 |
| May 13, 2026 | Saik Andrew · officer: Chief Financial Officer | Sale | 11,139 | $9.94 |
| May 13, 2026 | Loomis David K · officer: VP, Chief Accounting Officer | Sale | 1,919 | $9.94 |
| May 13, 2026 | Cacace Angela M · officer: Chief Scientific Officer | Sale | 9,657 | $9.94 |
| Mar 19, 2026 | Berkowitz Noah · officer: Chief Medical Officer | Sale | 6,435 | $11 |
| Mar 12, 2026 | Teel Randy · director, officer: President and CEO | A-Award | 147,179 | $0.00 |
| Mar 9, 2026 | Morrison Briggs · director | Purchase | 20,000 | $13 |
| Mar 2, 2026 | Saik Andrew · officer: Chief Financial Officer | A-Award | 45,000 | $0.00 |
| Mar 2, 2026 | Berkowitz Noah · officer: Chief Medical Officer | A-Award | 45,000 | $0.00 |
| Mar 2, 2026 | Cacace Angela M · officer: Chief Scientific Officer | A-Award | 45,000 | $0.00 |
| Mar 2, 2026 | Teel Randy · director, officer: President and CEO | A-Award | 147,791 | $0.00 |
| Mar 2, 2026 | Cacace Angela M · officer: Chief Scientific Officer | A-Award | 67,000 | $13 |
| Mar 2, 2026 | Loomis David K · officer: VP, Chief Accounting Officer | A-Award | 12,420 | $0.00 |
| Mar 2, 2026 | Berkowitz Noah · officer: Chief Medical Officer | A-Award | 67,000 | $13 |
Institutional positioning
13F filings over the trailing two quarters
New 72Increased 142Reduced 125Sold out 38
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 7,609,123 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 6,797,584 | May 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 4,123,399 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 3,889,628 | May 8, 2026 |
| D. E. SHAW & CO., INC. | Reduced | 3,638,567 | May 15, 2026 |
| D. E. Shaw & Co., Inc. | Reduced | 3,495,153 | Aug 14, 2026 |
| PFIZER INC | Unchanged | 3,457,815 | May 12, 2026 |
| PFIZER INC | Unchanged | 3,457,815 | Aug 13, 2026 |
| ARMISTICE CAPITAL, LLC | Increased | 2,796,000 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 2,714,163 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,689,362 | May 15, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 2,573,447 | Aug 14, 2026 |
| TCG CROSSOVER MANAGEMENT, LLC | Reduced | 2,387,461 | May 15, 2026 |
| STATE STREET CORP | Increased | 2,196,872 | Aug 7, 2026 |
| ARMISTICE CAPITAL, LLC | Increased | 1,978,000 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 26, 2026